期刊文献+

双重打击淋巴瘤的临床特征和治疗探讨

Re exploration of double-hit lymphomas
下载PDF
导出
摘要 目的探讨双重打击淋巴瘤的病理表现、治疗方法和治疗效果。方法 2013年1月-2015年10月接受治疗的双重打击淋巴瘤的患者3例,患者采用DA-EPOCH-R化疗模式。结果随访后显示患者胸部CT检查中肝脏右叶的低密度病灶明显减小,胃肠道部位异常密度阴影明显降低,腹膜淋巴结肿大症状明显减轻,患者恢复良好。结论双重打击淋巴瘤患者的病变症状较为明显,采用DA-EPOCH-R治疗的方式能够有效治疗。 Objective To investigate the lymphoma pathology, treatment methods and treatment effect of double-hit lymphomas. Methods From January 2013 to October 2015 in our hospital, three cases of double-hit lymphomas patients were received as the objects, and detected the patients' blood,blood biochemistry, urine, tumor markers, chest CT, gastroscopy and examination of bone marrow tissue immunity. All the patients, were treated with DAEPOCH-R therapy. Results The follow-up chest CT examination showed that patients' low-density lesions of the right lobe of the liver was significantly reduced, gastrointestinal site abnormal density shadow significantly reduce, retroperitoneal lymph nodes reduced significantly. The patients recovered well. Conclusion The symptoms of double-hit lymphomas are more obvious, and DA-EPOCH-R therapy is an effective mannerin the treatment.
作者 范丹丹
出处 《中国处方药》 2016年第9期135-136,共2页 Journal of China Prescription Drug
关键词 双重打击淋巴瘤 检验 治疗 效果 Double-hit lymphomas Testing Treatment Effect
  • 相关文献

参考文献4

二级参考文献67

  • 1朱雄增.弥漫性大B细胞淋巴瘤研究进展[J].临床与实验病理学杂志,2005,21(3):262-265. 被引量:16
  • 2Kanagal-Shamanna R, Medeiros W, Lu G, et al. High-grade B cell lymphoma, unclassifiable , with blastoid features: an unusual morphological subgroup associated frequently with BCU andl or MYC gene rearrangements and a poor prognosis. Histopathology, 2012,61 (5) :945-954.
  • 3Stasik CJ, Nitta H, Zhang W, et al. Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma. Haematologica ,2010, 95 (4) :597 03.
  • 4Foot NJ, Dunn RG, Geoghegan H, et al. Fluorescence in situ hybridisation analysis of formalin-fixed paraffin-embedded tissue sections in the diagnostic work-up of non-Burkitt high grade B-cell non-Hodgkin's lymphoma: a single centre's experience.J Clin Pathol,2011 ,64(9) :802-808.
  • 5Lindsley RC, LaCasce AS. Biology of double-hit B-cell lymphomas. Curr Opin Hematol ,2012,19 (4) :299-304.
  • 6Kobayashi T, Tsutsumi Y, Sakamoto N, et al. Double-hit lymphomas constitute a highly aggressive subgroup in diffuse large B-cell lymphomas in the era of rituximab. IpnJ Clin Oncol ,2012, 42 ( II ) : 1035 -1042.
  • 7Mationg-Kalaw E, Tan LH, Tay K, et al. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations? Histopathology,2012,61 (6) :1214-1218.
  • 8Lin P, Dickason TJ, Fayad LE, et al. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Cancer ,2012,118 (6) : 1566-1573.
  • 9Johnson NA, Savage KJ, Ludkovski 0, et al. Lymphomas with concurrent BC[2 and MYC translocations , the critical factors associated with survival. Blood,2009, 114(11) :2273-2279.
  • 10Snuderl M, Kolman OK, Chen YB, et al. B-cell lymphomas with concurrent IgH-BCU and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. AmJ Surg Pathol ,2010 ,34 (3) :327 -340.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部